Crystal Egg Bio is a biopharmaceutical research company engaged in the development of membrane protein drugs for treating major diseases.
Crystal Egg is a biopharmaceutical company dedicated to the independent research and development of first in class innovative new drugs for major diseases such as depression, chronic kidney disease, pain and rare diseases, as well as providing customers with high-quality products and R&D services in membrane protein-related fields. enterprise. The company has built membrane protein expression and purification platforms, structural biology platforms, pharmacology platforms and nanobody screening platforms, and has rich R&D pipelines in the fields of ion channels and GPCRs.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 7, 2022 | Seed | — | 1 | Longmen Capital | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Longmen Capital | Yes | Seed |